<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-SOK6VO9U</identifier><date>2016</date><creator>Schmidt, Mathias</creator><relation>documents/doc/S/URN_NBN_SI_doc-SOK6VO9U_001.pdf</relation><relation>documents/doc/S/URN_NBN_SI_doc-SOK6VO9U_001.txt</relation><format format_type="issue">4</format><format format_type="volume">85</format><format format_type="type">article</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">286467072</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-SOK6VO9U</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">izoflavoni</subject><subject language_type_id="slv">menopavza</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">vročinski oblivi</subject><subject language_type_id="slv">zdravljenje</subject><title>Sojini izoflavoni kot pristop prve izbire pri zdravljenju vazomotoričnih težav v menopavzi</title><title>Soy isoflavones as a first-line approach to the treatment of vasomotor symptoms of menopause</title></Record>